{
  "ticker": "UNH",
  "target_date": "2025-09-25",
  "actual_date": "2025-09-25",
  "collected_at": "2025-12-08T12:19:43.237241",
  "price": {
    "open": 348.9,
    "high": 350.19,
    "low": 343.6,
    "close": 345.55999755859375,
    "volume": 8104900,
    "change_1d_pct": -1.78,
    "change_7d_pct": 1.7,
    "change_30d_pct": 27.93
  },
  "technicals": {
    "rsi_14": 69.2,
    "sma_20": 332.02,
    "sma_50": 298.04,
    "macd": 13.651,
    "macd_signal": 14.146,
    "macd_histogram": -0.495,
    "bb_upper": 368.68,
    "bb_lower": 295.37,
    "price_vs_sma20_pct": 4.08,
    "price_vs_sma50_pct": 15.94,
    "volume_ratio": 0.59
  },
  "fundamentals": {
    "market_cap": 295715536896,
    "pe_ratio": 17.011724,
    "forward_pe": 10.918227,
    "price_to_book": 3.0877748,
    "price_to_sales": 0.67955744,
    "profit_margin": 4.04,
    "operating_margin": 3.81,
    "roe": 17.48,
    "roa": 5.36,
    "revenue_growth": 12.2,
    "earnings_growth": -60.2,
    "debt_to_equity": 75.734,
    "current_ratio": 0.823,
    "quick_ratio": 0.745,
    "dividend_yield": 267.0,
    "fifty_two_week_high": 606.36,
    "fifty_two_week_low": 234.6,
    "fifty_day_avg": 342.1196,
    "two_hundred_day_avg": 361.9156,
    "analyst_target": 388.52,
    "analyst_recommendation": "buy",
    "num_analysts": 25,
    "sector": "Healthcare",
    "industry": "Healthcare Plans",
    "pct_from_52w_high": -46.16,
    "pct_from_52w_low": 39.15
  },
  "macro": {
    "spy": {
      "price": 658.05,
      "change_1d_pct": -0.46,
      "change_7d_pct": 0.11
    },
    "vix": {
      "level": 16.74,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.17
    },
    "dollar_index": {
      "level": 98.55
    },
    "gold": {
      "price": 3736.9
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "UnitedHealth Group (UNH) Dips More Than Broader Market: What You Should Know",
      "source": "Yahoo",
      "datetime": 1758836703,
      "summary": "In the latest trading session, UnitedHealth Group (UNH) closed at $345.56, marking a -1.78% move from the previous day.",
      "url": "https://finnhub.io/api/news?id=6512362634c685745906adc20d1a734ec62bdcf1044aae73e3140e0e40345c66"
    },
    {
      "headline": "Warren Buffett Just Dumped the Last of His BYD Stock. Should You Give Up, Too?",
      "source": "Yahoo",
      "datetime": 1758830816,
      "summary": "After 17 years, Berkshire Hathaway has exited its position in BYD.",
      "url": "https://finnhub.io/api/news?id=ef800249ccd992af15d6077e60ac32b550d6f03acc4f352c8b22305233703098"
    },
    {
      "headline": "UnitedHealth Group (UNH) Slid Due to Decline in Investor Confidence",
      "source": "Yahoo",
      "datetime": 1758808692,
      "summary": "PGIM, an investment management company, released its \u201cPGIM Jennison Health Sciences Fund\u201d second-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities in the second quarter of 2025 experienced significant volatility, as the steep sell-off that initiated at the beginning",
      "url": "https://finnhub.io/api/news?id=bef193b88e79d6fffca161878639ff842f2d26152c7e1e0f4c5c59101471cbbf"
    },
    {
      "headline": "Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit",
      "source": "Yahoo",
      "datetime": 1758799869,
      "summary": "CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with UnitedHealthcare insurance company, a unit of UnitedHealth Group Inc. (NYSE: UNH). Effective September 15, the agreement covers over 51 million people throughout the United S",
      "url": "https://finnhub.io/api/news?id=b9910ee42554bc70f5e330a4a8307d49969965d7e64d01e695fac31f4f6f022a"
    },
    {
      "headline": "Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare Insurance Company for CNSide\u00ae Cerebrospinal Fluid Assay for Metastatic CNS Cancer",
      "source": "Yahoo",
      "datetime": 1758799800,
      "summary": "HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (\u201cPlus\u201d or the \u201cCompany\u201d), announced today that it has signed a national agreement with UnitedHealthcare Insurance Company (NYSE: UNH), effective September 15, 202",
      "url": "https://finnhub.io/api/news?id=49d7c513713acaa10b1b9a1c6b4fc1038a881a6f110a453c9bacee02e692e44e"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-09-25",
      "description": "xslF345X05/wk-form4_1758831394.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176625000281/xslF345X05/wk-form4_1758831394.xml"
    },
    {
      "form": "4",
      "date": "2025-09-25",
      "description": "xslF345X05/wk-form4_1758831385.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176625000280/xslF345X05/wk-form4_1758831385.xml"
    },
    {
      "form": "4",
      "date": "2025-09-25",
      "description": "xslF345X05/wk-form4_1758831379.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176625000279/xslF345X05/wk-form4_1758831379.xml"
    },
    {
      "form": "4",
      "date": "2025-09-25",
      "description": "xslF345X05/wk-form4_1758831371.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176625000278/xslF345X05/wk-form4_1758831371.xml"
    },
    {
      "form": "4",
      "date": "2025-09-25",
      "description": "xslF345X05/wk-form4_1758831365.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/731766/000073176625000277/xslF345X05/wk-form4_1758831365.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}